Inicio>>Signaling Pathways>> PROTAC>>Boc-C1-PEG3-C4-OBn

Boc-C1-PEG3-C4-OBn

Catalog No.GC39350

Boc-C1-PEG3-C4-OBn (PROTAC Linker 15) es un conector PROTAC, que se refiere a la composiciÓn de PEG. Boc-C1-PEG3-C4-OBn se puede utilizar en la sÍntesis de una serie de PROTAC, como PROTAC SGK3 degradador-1. Los PROTAC contienen dos ligandos diferentes conectados por un enlazador; uno es un ligando para una ubiquitina ligasa E3 y el otro es para la proteÍna diana. Los PROTAC aprovechan el sistema intracelular de ubiquitina-proteasoma para degradar selectivamente las proteÍnas diana.

Products are for research use only. Not for human use. We do not sell to patients.

Boc-C1-PEG3-C4-OBn Chemical Structure

Cas No.: 2381196-81-0

Tamaño Precio Disponibilidad Cantidad
500mg
603,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Boc-C1-PEG3-C4-OBn (PROTAC Linker 15) is a PROTAC linker, which refers to the PEG composition. Boc-C1-PEG3-C4-OBn can be used in the synthesis of a series of PROTACs, such as PROTAC SGK3 degrader-1. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].

[1]. Tovell H, et al. Design and Characterization of SGK3-PROTAC1, an Isoform Specific SGK3 Kinase PROTACDegrader. ACS Chem Biol. 2019 Sep 20;14(9):2024-2034.

Reseñas

Review for Boc-C1-PEG3-C4-OBn

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Boc-C1-PEG3-C4-OBn

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.